Sanofi profit lifted by early vaccine sales, dupixent growth admin 2 weeks ago News Comments Off on Sanofi profit lifted by early vaccine sales, dupixent growth 0 Views Earnings per share excluding some items reached €2.86 ($3.10) in the third quarter, exceeding analysts’ estimates. Read More Share Facebook Twitter Stumbleupon LinkedIn Pinterest
